Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines

British Journal of Cancer

Volumn 83, Issue 6, 2000, Pages 782-791

  Tonetti, D A ^a   Chisamore, M J ^a   Grdina, W ^a   Schurz, H ^a   Jordan, V C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AP 1; Breast cancer; Hormone independent; Protein kinase C; Tamoxifen resistance

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR; ISOENZYME; PROTEIN KINASE C; TAMOXIFEN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CLONE; CELL STRAIN MCF 7; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033821711     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1326     Document Type: Article

References (45)

1. The role of Jun, Fos and the AP-I complex in cell-proliferation and transformation
2. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region
3. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
4. Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-f-mediated response: Involvement of the estrogen receptor
5. 2+-dependent protein kinase of human mammary carcinoma cells: Inverse relationships to estrogen receptors
6. Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue
7. Activation and inhibition of the AP-complex in human breast cancer cells
8. Protein kinase C and breast cancer
9. Protein kinase C-a question of specificity
10. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by clevated levels of AP-1 DNA-binding activity
11. Measurement of steroid hormone receptors in brcast cancer patients on tamoxifen
12. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue
13. Functional divergence of protein kinase C (PKC) family members. PKC gamma differs from PKC alpha and -beta II and nPKC epsilon in its competence to mediate-12-O-tetradecanoyl phorbol 13-acetate (TPA)- responsive transcriptional activation through a TPA-response clement
14. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol
15. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness [ln Process Citation]
16. Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer
17. Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance
18. Estrogen receptor mutations in tamoxifen-resistant breast cancer
19. Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes
20. A simple, rapid, and sensitive DNA assay procedure
21. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
22. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic in mice
23. Induction of a less aggressive breast cancer phenotype by protein kinase c-α and -β overexpression
24. Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells
25. Protein kinase C and its isoforms in human breast cancer cells: Relationship to the invasive phenotype
26. PKCalpha regulates betal integrin-dependent cell motility through association and control of integrin traffic
27. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
28. Luciferase reporter gene vectors for analysis of promoters and enhancers
29. Elevated protein kinase C expression in human breast tumor biopsics relative to normal breast tissue
30. Mechanisms for tamoxifen resistance in breast cancer: Possible role of tamoxifen metabolism
31. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis
32. An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein
33. Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation
34. Breast cancer cell invasiveness: Correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells
35. Protein kinase C isozymes differentially regulate promoters containing PEA-3/12-O-tetradecanoylphorbol-13-acetate response element motifs
36. Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate
37. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype
38. Overexpression of protein kinase Calpha in MCF-10A human breast cells engenders dramatic alterations n morphology proliferation, and motility [In Process Citation]
39. Possible mechanisms in the emergence of tamoxifen-resistant breast cancer
40. Protein kinasc C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation
41. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype
42. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
43. The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain
44. Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites
45. Phorbol eater and epidermal growth factor receptors in human breast cancer